Moleculin Biotech, Inc. — 424B5 Filings
21 424B5 filings on record
This page lists all 424B5 filings submitted to the SEC by Moleculin Biotech, Inc. (MBRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Moleculin Biotech, Inc. has filed 21 424B5 documents with the SEC since 2015. To view all SEC filings by Moleculin Biotech, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | FORM 424B5 | 0001437749-25-038686 | Dec 23, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-022604 | Jul 11, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-005173 | Feb 26, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-23-035262 | Dec 22, 2023 | — |
| 424B5 | FORM 424B5 | 0001437749-21-015714 | Jun 25, 2021 | — |
| 424B5 | FORM 424B5 | 0001437749-21-015712 | Jun 25, 2021 | — |
| 424B5 | FORM 424B5 | 0001437749-21-002001 | Feb 4, 2021 | — |
| 424B5 | FORM 424B5 | 0001437749-21-001760 | Feb 2, 2021 | — |
| 424B5 | FORM 424B5 | 0001437749-21-001750 | Feb 2, 2021 | — |
| 424B5 | FORM 424B5 | 0001437749-21-001749 | Feb 2, 2021 | — |
| 424B5 | FORM 424B5 | 0001437749-20-023649 | Nov 12, 2020 | — |
| 424B5 | 424B5 | 0001104659-20-084557 | Jul 17, 2020 | — |
| 424B5 | 424B5 | 0001104659-20-012016 | Feb 6, 2020 | — |
| 424B5 | 424B5 | 0001104659-20-011647 | Feb 6, 2020 | — |
| 424B5 | 424B5 | 0001144204-19-035669 | Jul 24, 2019 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001144204-19-020802 | Apr 24, 2019 | — |
| 424B5 | 424B5 | 0001144204-19-016728 | Mar 29, 2019 | — |
| 424B5 | 424B5 | 0001144204-19-016030 | Mar 26, 2019 | — |
| 424B5 | 424B5 | 0001144204-18-035170 | Jun 21, 2018 | — |
| 424B5 | 424B5 | 0001144204-18-009545 | Feb 16, 2018 | — |
| 424B5 | 424B5 | 0001144204-17-048291 | Sep 15, 2017 | — |